Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Groberg, 5 are a HOLD (62.5%), 1 are a SELL (12.5%), 2 are a BUY (25%).
Analyst Jonathan Groberg, carries an average stock price target met ratio of 83.33% that have a potential upside of 26.46% achieved within 394 days. Previously, Jonathan Groberg worked at UBS.
Jonathan Groberg’s has documented 16 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on A, Agilent Technologies at 15-Feb-2017.
Analyst best performing recommendations are on A (AGILENT TECHNOLOGIES).
The best stock recommendation documented was for A (AGILENT TECHNOLOGIES) at 2/15/2017. The price target of $50 was fulfilled within 28 days with a profit of $2.02 (4.21%) receiving and performance score of 1.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Sep-2026
$340
$-5.37 (-1.55%)
$195
29 days ago
(28-Sep-2026)
34/35 (97.14%)
$45.41 (15.41%)
227
Buy Since 09-Jul-2025
$330
$-15.37 (-4.45%)
$320
1 months 2 days ago
(25-Sep-2026)
11/11 (100%)
$37.16 (12.69%)
157
Buy Since 06-Aug-2026
$322
$-23.37 (-6.77%)
$282
1 months 2 days ago
(25-Sep-2026)
2/2 (100%)
$29.16 (9.96%)
16
Buy Since 06-Nov-2025
$330
$-15.37 (-4.45%)
$220
1 months 2 days ago
(25-Sep-2026)
14/14 (100%)
$37.16 (12.69%)
51
Hold Since 07-Jun-2024
$295
$-50.37 (-14.58%)
$230
1 months 2 days ago
(25-Sep-2026)
11/11 (100%)
$2.16 (0.74%)
34